Literature DB >> 33419611

State of the Science: The role of HIPEC in the treatment of ovarian cancer.

Thanh H Dellinger1, Ernest S Han2.   

Abstract

Entities:  

Keywords:  Hyperthermic intraperitoneal chemotherapy (HIPEC); Ovarian cancer

Mesh:

Year:  2021        PMID: 33419611     DOI: 10.1016/j.ygyno.2020.12.029

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.

Authors:  Thanh H Dellinger; Ernest S Han; Mustafa Raoof; Byrne Lee; Xiwei Wu; Hyejin Cho; Ting-Fang He; Peter Lee; Marianne Razavi; Winnie S Liang; Daniel Schmolze; Saul J Priceman; Stephen Lee; Wei-Chien Lin; Jeff F Lin; Mehdi Kebria; Amy Hakim; Nora Ruel; Daphne B Stewart; Edward W Wang; Benjamin I Paz; Mark T Wakabayashi; Mihaela C Cristea; Lorna Rodriguez-Rodriguez
Journal:  JCO Precis Oncol       Date:  2022-03

2.  Cytoreductive Surgery (CRS) Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Platinum-Sensitive Recurrence Epithelial Ovarian Cancer With HRR Mutation: A Phase III Randomized Clinical Trial.

Authors:  Yuwen Qi; Yaxing Zhang; Yuying Shi; Shijie Yao; Mengyuan Dai; Hongbing Cai
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 3.  Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers.

Authors:  Pei-Qi Lim; I-Hung Han; Kok-Min Seow; Kuo-Hu Chen
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.